MESALAZINE Side Effects

6858016-1 | Diffuse Alveolar Damage, Interstitial Lung Disease
on Jun 30, 2010 Female patient from UNITED STATES , 70 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Mesalazine (View Usage). Patient experienced the following unwanted or unexpected effects: diffuse alveolar damage, interstitial lung disease. Mesalazine dosage: . Patient was hospitalized.

6735547-6 | Haemolysis, Influenza
Patient was taking Mesalazine (View Usage). Patient had the following side effects: haemolysis, influenza on May 13, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 68 years of age, weighting 130.1 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Mesalazine dosage: . During the same period patient was treated with H1N1 INFLUENZA VACCINE (View H1n1 Influenza Vaccine Review and H1n1 Influenza Vaccine Label ).

6653978-X | Pleurisy
Adverse event was reported on Mar 26, 2010 by a Male patient taking Mesalazine (View Usage) (Dosage: ) was diagnosed with colitis ulcerative, influenza and. Location: ITALY , 23 years of age, After Mesalazine was administered, patient had the following side effects: pleurisy. During the same period patient was treated with SALICYLIC ACID (View Salicylic Acid Review and Salicylic Acid Label ).

6434792-7 | Interstitial Lung Disease
on Nov 02, 2009 Female patient from ITALY , 32 years of age, was diagnosed with colitis ulcerative and was treated with Mesalazine (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Mesalazine dosage: . Patient was hospitalized.


6255118-8 | Haemolysis, Hepatic Function Abnormal, Platelet Count Decreased
on Jun 23, 2009 Female patient from ITALY , 70 years of age, was treated with Mesalazine (View Usage). Patient had the following side effects: haemolysis, hepatic function abnormal, platelet count decreased. Mesalazine dosage: . Patient was hospitalized.

6096682-1 | Pleurisy
Patient was taking Mesalazine (View Usage). After Mesalazine was administered, patient had the following side effects: pleurisy on Feb 16, 2009 from ITALY Additional patient health information: Male patient , 23 years of age, was diagnosed with colitis ulcerative, influenza and. Mesalazine dosage: . During the same period patient was treated with SALICYLIC ACID (View Salicylic Acid Review and Salicylic Acid Label ).

5317850-X | Allergic Granulomatous Angiitis
Adverse event was reported on Apr 13, 2007 by a Male patient taking Mesalazine (View Usage) (Dosage: ) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: ITALY , 39 years of age, Patient experienced the following unwanted or unexpected effects: allergic granulomatous angiitis. During the same period patient was treated with URSODIOL (View Ursodiol Review and Ursodiol Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ).

5304379-8 | Anaemia, Electrocardiogram Qt Corrected Interval Prolonged, Haemoglobin Decreased, Platelet Count Increased, Tachycardia
on Apr 13, 2007 Female patient from UNITED KINGDOM , 19 years of age, was diagnosed with crohn's disease (What is crohn's disease?), schizophrenia and was treated with Mesalazine (View Usage). Patient had the following side effects: anaemia, electrocardiogram qt corrected interval prolonged, haemoglobin decreased, platelet count increased, tachycardia. Mesalazine dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), DEPAKOTE (View Depakote Review and Depakote Label ), CLOZARIL (View Clozaril Review and Clozaril Label ).

5301702-5 | Anaemia, Electrocardiogram Qt Corrected Interval Prolonged, Haemoglobin Decreased, Tachycardia
on Apr 06, 2007 Female patient from UNITED KINGDOM , 19 years of age, was diagnosed with crohn's disease (What is crohn's disease?), schizophrenia and was treated with Mesalazine (View Usage). After Mesalazine was administered, patient had the following side effects: anaemia, electrocardiogram qt corrected interval prolonged, haemoglobin decreased, tachycardia. Mesalazine dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), DEPAKOTE (View Depakote Review and Depakote Label ), CLOZARIL (View Clozaril Review and Clozaril Label ).

5284359-1 | Anaemia, Blood Fibrinogen Increased, C-reactive Protein Increased, Condition Aggravated, Erythema Nodosum, Gait Disturbance, Infective Myositis, Muscle Swelling
Patient was taking Mesalazine (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, blood fibrinogen increased, c-reactive protein increased, condition aggravated, erythema nodosum, gait disturbance, infective myositis, muscle swelling on Mar 15, 2007 from CROATIA (local name: Hrvatska) Additional patient health information: Male patient , 13 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and. Mesalazine dosage: 1500 Mg Qday. During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ). Patient was hospitalized.

5268899-7 | Blood Alkaline Phosphatase Increased, Nephritis Interstitial, Pericarditis
Adverse event was reported on Mar 01, 2007 by a Male patient taking Mesalazine (View Usage) (Dosage: 3 G Qday Unk) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: FRANCE , 44 years of age, Patient had the following side effects: blood alkaline phosphatase increased, nephritis interstitial, pericarditis. Patient was hospitalized.

5226767-0 | Anaemia, Colitis Ulcerative, Condition Aggravated, Inflammation, Leukocyturia, Nephritis Interstitial, No Therapeutic Response, Proteinuria
on Jan 17, 2007 Female patient from BELGIUM , child 11 years of age, was treated with Mesalazine (View Usage). After Mesalazine was administered, patient had the following side effects: anaemia, colitis ulcerative, condition aggravated, inflammation, leukocyturia, nephritis interstitial, no therapeutic response, proteinuria. Mesalazine dosage: 1500 (500 Mg, 3 In 1 D). Patient was hospitalized.

5218624-0 | Lung Disorder, Lung Injury
on Jan 09, 2007 Male patient from POLAND , 35 years of age, was diagnosed with colitis ulcerative and was treated with Mesalazine (View Usage). Patient experienced the following unwanted or unexpected effects: lung disorder, lung injury. Mesalazine dosage: Df. During the same period patient was treated with SULFASALAZINE (Df) (View Sulfasalazine Review and Sulfasalazine Label ).

5162045-6 | Tuberculosis
Patient was taking Mesalazine (View Usage). Patient had the following side effects: tuberculosis (What is tuberculosis?) on Nov 09, 2006 from POLAND Additional patient health information: Male patient , 35 years of age, was diagnosed with colitis ulcerative and. Mesalazine dosage: Df. During the same period patient was treated with SULFASALAZINE (Df) (View Sulfasalazine Review and Sulfasalazine Label ).

5147128-9 | Antinuclear Antibody Increased, Cryptogenic Organising Pneumonia, Pleural Effusion
Adverse event was reported on Oct 19, 2006 by a Female patient taking Mesalazine (View Usage) (Dosage: 4 G Qday Unk) was diagnosed with colitis ulcerative and. Location: NEW ZEALAND , 31 years of age, After Mesalazine was administered, patient had the following side effects: antinuclear antibody increased, cryptogenic organising pneumonia, pleural effusion. Patient was hospitalized.

5129280-4 | Allergic Granulomatous Angiitis, Arthralgia, Blastocystis Infection, Bone Marrow Eosinophilic Leukocyte Count Increased, Cerebral Ischaemia, Emphysema, Fungus Stool Identified, Hyperacusis, Iiird Nerve Paralysis
on Sep 25, 2006 Male patient from ALBANIA , 39 years of age, was diagnosed with cholangitis sclerosing, crohn's disease (What is crohn's disease?) and was treated with Mesalazine (View Usage). Patient experienced the following unwanted or unexpected effects: allergic granulomatous angiitis, arthralgia, blastocystis infection, bone marrow eosinophilic leukocyte count increased, cerebral ischaemia, emphysema, fungus stool identified, hyperacusis, iiird nerve paralysis. Mesalazine dosage: Df. During the same period patient was treated with SALBUTAMOL (View Salbutamol Review and Salbutamol Label ), URSODEOXYCHOLIC ACID (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ). Patient was hospitalized.

5065711-6 | Sinus Bradycardia
on Jul 14, 2006 Male patient from SPAIN , 17 years of age, was diagnosed with ileitis and was treated with Mesalazine (View Usage). Patient had the following side effects: sinus bradycardia. Mesalazine dosage: 1 G Q8hr Po. During the same period patient was treated with METHYLPREDNISOLONE (40 Mg Q8hr Iv) (View Methylprednisolone Review and Methylprednisolone Label ), CEFTRIAXONE (1 G Q12hr Iv) (View Ceftriaxone Review and Ceftriaxone Label ), METRONIDAZOLE (500 Mg Q8hr Iv) (View Metronidazole Review and Metronidazole Label ). Patient was hospitalized.

4989886-X | Intestinal Infarction
Patient was taking Mesalazine (View Usage). After Mesalazine was administered, patient had the following side effects: intestinal infarction on Apr 27, 2006 from UNITED KINGDOM Additional patient health information: Male patient , 35 years of age, was diagnosed with colitis ulcerative and. Mesalazine dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LOW MOLECULAR WEIGHT HEPARIN (View Low Molecular Weight Heparin Review and Low Molecular Weight Heparin Label ). Patient was hospitalized.

4968710-5 | Extranodal Marginal Zone B-cell Lymphoma (malt Type)
Adverse event was reported on Mar 23, 2006 by a Female patient taking Mesalazine (View Usage) (Dosage: Daily Dose: 3 Milligram(s) Per Day) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: SPAIN , 79 years of age, Patient experienced the following unwanted or unexpected effects: extranodal marginal zone b-cell lymphoma (malt type).

4961683-0 | Extranodal Marginal Zone B-cell Lymphoma (malt Type)
on Mar 23, 2006 Female patient from SPAIN , 79 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Mesalazine (View Usage). Patient had the following side effects: extranodal marginal zone b-cell lymphoma (malt type). Mesalazine dosage: .